Comparative Pharmacology
Head-to-head clinical analysis: CLINIMIX 4 25 25 SULFITE FREE IN DEXTROSE 25 IN PLASTIC CONTAINER versus CLINIMIX 4 25 5 SULFITE FREE IN DEXTROSE 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLINIMIX 4 25 25 SULFITE FREE IN DEXTROSE 25 IN PLASTIC CONTAINER versus CLINIMIX 4 25 5 SULFITE FREE IN DEXTROSE 5 IN PLASTIC CONTAINER.
CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER vs CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Parenteral nutrition providing amino acids for protein synthesis, dextrose as a carbohydrate calorie source, and electrolytes to maintain physiologic homeostasis.
CLINIMIX 4.25/5 is a parenteral nutrition solution providing amino acids and dextrose for protein synthesis and energy metabolism. Amino acids serve as substrates for protein synthesis, while dextrose provides a source of glucose for cellular energy production via glycolysis and oxidative phosphorylation.
Intravenous infusion only. Dosing is individualized based on patient's metabolic needs, weight, and clinical status. Typical adult dose: 1-2 L/day of CLINIMIX 4.25/25, providing 4.25% amino acids and 25% dextrose. Infusion rate should not exceed 3 mg/kg/min for dextrose. Adjust for caloric and nitrogen requirements.
IV, dosage individualized based on protein and energy requirements. Typical adult dose: 1.5 g/kg/day of amino acids (4.25% solution) as part of total parenteral nutrition, infused at a rate not exceeding 0.1 g/kg/hour.
None Documented
None Documented
Not applicable; components are endogenous substances. Amino acids have rapid clearance (minutes to hours) depending on metabolic demand; dextrose half-life ~1-2 hours in euglycemic state.
Amino acids: variable, with terminal half-life of individual amino acids ranging from 0.5 to 3 hours. Clinical context: continuous infusion maintains steady-state levels; used for nutritional support.
Amino acids: primarily renal as urea (via ureagenesis) and some as ammonia; dextrose: metabolized to CO2 and water, excreted via lungs and urine. Not applicable as combination product.
The components (amino acids and dextrose) are metabolized; excess nitrogen is excreted renally as urea (about 85-90%), with minor fecal loss (<5%). Dextrose is fully metabolized to CO2 and water, with negligible renal excretion.
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition